Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat

Journal of Bone and Mineral Research

Volumn 15, Issue 10, 2000, Pages 2033-2041

  Wezeman, Frederick H ^a   Emanuele, Mary Ann ^a   Moskal, Stanley F ^a   Steiner, Jennifer ^a   Lapaglia, Nancy ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Alcohol; Alendronate; Bisphosphonate; Bone; Rat

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; BONE MINERAL; COLLAGEN TYPE 1; LUTEINIZING HORMONE; OSTEOCALCIN; SOMATOMEDIN C; TESTOSTERONE;

ADOLESCENT; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MINERALIZATION; BONE STRENGTH; CONTROLLED STUDY; DOT HYBRIDIZATION; GENE EXPRESSION; MALE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOMALACIA; OSTEOPOROSIS; RAT;

ALCOHOLISM; ALENDRONATE; ALKALINE PHOSPHATASE; ANIMAL; BIOMECHANICS; BONE AND BONES; BONE DENSITY; COLLAGEN; ETHANOL; FEMUR; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; MALE; OSTEOCALCIN; OSTEOPOROSIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEX MATURATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TESTOSTERONE; WEIGHT GAIN;

EID: 0033809718     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.10.2033     Document Type: Article

References (67)

1. Bone changes after alcohol abuse
2. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength
3. Alcohol-induced bone disease: Impact of ethanol on osteoblast proliferation
4. Ethanol inhibits human osteoblastic cell proliferation
5. Inhibition of osteoblastic cell proliferation and ornithine decarboxylase activity by ethanol
6. In vitro evaluation of dose-effects of ethanol on osteoblastic cells
7. Effects of ethanol on gene expression in rat bone: Transient dose-dependent changes in mRNA levels for matrix proteins, skeletal growth factors, and cytokines are followed by reductions in bone formation
8. Ethanol inhibits human bone cell proliferation and function in vitro
9. Alcohol consumption inhibits osteoblastic cell proliferation and activity in vivo
10. Low serum osteocalcin in acute alcohol intoxication: A direct toxic effect of alcohol on osteoblasts
11. Alcohol consumption by young actively growing rats: A study of cortical bone histomorphometry and mechanical properties
12. Ethanol-induced changes in morphology and strength of femurs of rats
13. Bone density and fracture risk in men
14. Identification of alcohol abuse: Thoracic fractures on routine chest x-rays as indicators of alcoholism
15. Alcohol consumption by young actively growing rats: A histomorphometric study of cancellous bone
16. Alcohol consumption inhibits bone growth and development in young actively growing rats
17. Alcohol and bone
18. Alcohol-induced bone disease
19. Alcohol abuse and osteoporosis
20. Effect of alcohol on adult and aged bone: Composition, morphology, and hormone levels of a rat animal model
21. Effect of alcohol consumption on adult and aged bone: A histomorphometric study of the rat animal model
22. Effect of heavy alcohol intake in the absence of liver disease on bone mass in black and white men
23. Biochemical markers of bone metabolism after short and long term ethanol withdrawal in alcoholics
24. Vertebral bone density and its correlation with various factors related to bone metabolism in alcoholics: A quantitative study by computed tomography
25. Bone histomorphometry, bone mass, and related parameters in alcoholic males
26. Mechanisms of hypocalcemia and markers of bone turnover in alcohol-intoxicated drinkers
27. Alcohol, osteopenia, and bone regulating hormones
28. Long term alcohol consumption in the rat affects femur cross-sectional geometry and bone tissue material properties
29. The urinary excretion of the collagen markers pyridinoline and deoxypyridinoline in an experimental rat model of alcoholic bone disease
30. Mineral metabolism osteoblastic function and bone mass in chronic alcoholism
31. Human endosteal osteoblastic cells: Relationship with bone formation
32. Bisphosphonates: Mode of action
33. The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals
34. Bisphosphonates: Mechanisms of action
35. Bisphosphonate action: Alendronate localization in rat bone and effects on osteoclast ultrastructure
36. Bisphosphonates act on osteobastic cells and inhibit osteoclast formation in mouse marrow cultures
37. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption
38. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts
39. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates
40. The effects of 1-hydroxyethane-1,1-diphosphonate and dichloromethanediphosphonate on collagen synthesis by rabbit articular chondrocytes and rat bone cells
41. New bisphosphonates in osteoporosis
42. Comparison of alendronate and sodium fluoride effects on cancellous bone in minipigs: A one year study
43. Bisphosphonates stimulate formation of osteoblast precursors and nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo
44. Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat
45. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats
46. The effects of risedronate on canine cancellous bone remodeling: Three dimensional kinetic reconstruction of the remodeling site
47. The effect of 2 year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized non-human primates
48. Clinical effects of bisphosphonates in involutional osteoporosis
49. Changes in bone histomorphometry after long-term treatment with intermittent cyclic etidronate for postmenopausal osteoporosis
50. Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis
51. Effect of oral alendronate on bone mineral density and the incidence of fracture in postmenopausal osteoporosis
52. Four year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy
53. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
54. Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1
55. Binge drinking and bone metabolism in a young actively growing rat model
56. Natural history of drug use from adolescence to the mid-thirties in a general population sample
57. Self-recognition of alcohol and cigarette dependency among high school seniors
58. Osteopenia due to chronic alcohol consumption by young actively growing rats is not completely reversible
59. Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: Effects on bone morphometry and mineral properties
60. Clodronate increases the calcium content in fracture callus
61. Alendronate modulates osteogenesis of human osteoblastic cells in vitro
62. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropyllidene)-1,1-bisphosphonate (ADP)
63. Tiludronate: Bone pharmacology and safety
64. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHOP) and dichloromethylene diphosphonate (C12MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats
65. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: A histomorphometric analysis of transiliac biopsies
66. Alendronate reduces fractures without increasing bone strength in a growing mouse model of osteogenesis imperfecta
67. Increased bone diameter and strength in oim mice treated with alendronate